Michelle Keefe, the CEO who spent her 18-month tenure guiding health services giant Syneos Health through its going private transition in a $7 billion deal, has been replaced just days after the deal closed.
The Syneos deal was first announced in May with the unanimous approval of the board of directors and received approval from shareholders in early August.
/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Syneos Health, Inc. ("Syneos" or the "Company") (NASDAQ: SYNH). Such investors.
NEW YORK, Sept. 21, 2023 /PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Syneos Health, Inc. . Such investors are advised to contact Robert S. Willoughby at.